Drug Profile
NS 580
Alternative Names: NS-580Latest Information Update: 22 Aug 2023
Price :
$50
*
At a glance
- Originator Nippon Shinyaku
- Class Analgesics; Infertility therapies
- Mechanism of Action Prostaglandin-E synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Endometriosis; Pelvic pain; Prostatitis
Most Recent Events
- 21 Aug 2023 Phase-II clinical trials in Pelvic pain in Japan (PO) (Nippon Shinyaku pipeline; August 2023)
- 21 Aug 2023 Phase-II clinical trials in Prostatitis in Japan (PO) (Nippon Shinyaku pipeline; August 2023)
- 24 Sep 2020 Phase II development is ongoing in Endometriosis in Japan (Nippon Shinyaku pipeline; September 2020)